| 2451 |
EMLUTINI |
IBRUTINIB 140 MG |
CAPSULE |
BOTTLE |
IT IS USED TO TREAT THE FOLLOWING BLOOD CANCER. |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 0701/16 |
28-JUN-2023 |
27-JUN-2026 |
View |
| 2452 |
ENFLON |
EMPAGLIFLOZIN 10 MG |
FILM-COATED TABLETS |
BOTTLE |
ENFLONG IS A INSULIN 2 |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 0717/16 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 2453 |
ENSIDNIB |
ENASIDENIB 100 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF AML IN ADULTS PATIENTS WHOSE CANCER CELLS HAVE A MUTATION IN THE GENE FOR A PROTEIN CALLED IDH2 AND WHO CANNOT RECEIVE INTENSIVE CANCER TREATMENT |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1137/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 2454 |
ENSIDNIB |
ENASIDENIB 50 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF AML IN ADULTS PATIENTS WHOSE CANCER CELLS HAVE A MUTATION IN THE GENE FOR A PROTEIN CALLED IDH2 AND WHO CANNOT RECEIVE INTENSIVE CANCER TREATMENT |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1138/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 2455 |
ERDAINI |
ERDAFITINIB 3 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF BLADDER CANCER THAT HAS SPREAD OR CANNOT BE REMOVED BY SURGERY |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 0921/22 |
14-SEP-2022 |
13-SEP-2025 |
View |
| 2456 |
ERDAINI |
ERDAFITINIB 4 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF BLADDER CANCER THAT HAS SPREAD OR CANNOT BE REMOVED BY SURGERY |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 0922/22 |
14-SEP-2022 |
13-SEP-2025 |
View |
| 2457 |
ERDAINI |
ERDAFITINIB 5 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF BLADDER CANCER THAT HAS SPREAD OR CANNOT BE REMOVED BY SURGERY |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 0923/22 |
14-SEP-2022 |
13-SEP-2025 |
View |
| 2458 |
GIRUINI |
GILTERITINIB 40 MG |
TABLET |
BOTTLE |
TREATMENT OF ADULT PATIENTS WHO HAVE RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA WITH A FMS-LIKE TYROSINE KINASE 3 MUTATION |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 0943/22 |
09-DEC-2022 |
08-DEC-2025 |
View |
| 2459 |
IVONIB |
IVOSIDENIB 250 MG |
FILM COATED TABLET |
BOTTLE |
NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA, RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, LOCALLY ADVANCED OR METASTATIC CHOLANGIOCARCINOMA |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1149/24 |
2024-07-29 |
2027-07-28 |
View |
| 2460 |
KAYZONI |
CRIZOTINIB 250 MG |
CAPSULE |
BOTTE, BLISTERPACK |
TREATMENT OF NON-SMALL CELL LUNG CANCER RELATED GENE ANAPLASTIC LYMPHOMA KINASE (ALK) OR GENE CALLED ROSI |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 0751/17 |
21-AUG-2024 |
20-AUG-2027 |
View |
